Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies.

Journal of leukocyte biology - 1 Aug 2017

Lopez-Bujanda Zoila, Drake Charles G

Abstract excerpt

Prostate cancer is the second most common cause of cancer mortality in men in the United States. As is the case for other tumor types, accumulating evidence suggests an important role for myeloid-derived cells in the promotion and progression of prostate cancer. Here, we briefly describe myeloid-derived cells that interact with tumor cells and what is known about their immune suppressive function. We next discuss...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to PTEN gene
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammatory Biomarkers in Disease Prognosis

Share to Myeloid-Derived Suppressor Cells

Share to Phenotype

Share to Prostatic Neoplasms

Share to Tumor Escape

Source

Open in PubMed Open full text

Identifiers

PMID: 28550116
DOI: 10.1189/jlb.5VMR1116-491RR
PMCID: PMC6608078

Genes

PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies.PMID 28550116Read ↗

Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives.Semantic proximity Read ↗

Immunome profiling in prostate cancer: a guide for cliniciansSemantic proximity Read ↗

Regulation of prostate cancer progression by the tumor microenvironment.Semantic proximity Read ↗

Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challengesSemantic proximity Read ↗

New approaches and prospects of immunotherapy and gene therapy for prostate cancerSemantic proximity Read ↗

Correlation between high ratio of circulating PMN-MDSCs and poor prognosis in metastatic hormone sensitive prostate cancerSemantic proximity Read ↗

Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer ProgressionSemantic proximity Read ↗

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulatorSemantic proximity Read ↗

Therapeutic implications of cancer stem cells in prostate cancerSemantic proximity Read ↗

Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical PotentialSemantic proximity Read ↗

Mesenchymal stem cells and prostate cancer: A concise review of therapeutic potentials and biological aspectsSemantic proximity Read ↗

An oncogenotype-immunophenotype paradigm governing the myeloid landscape in genetically engineered mouse models of prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.